XML 65 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of stock based compensation plans
The Company has four active stock based compensation plans at June 30, 2022 as shown in the table below:
Date ApprovedName of PlanType of PlanAuthorized
Shares
June 20132013 Stock Incentive PlanStock500,000 
June 20142014 Stock Option Incentive PlanStock options750,000 
June 20152015 Equity Incentive PlanStock & stock options1,250,000 
April 20182018 Equity Incentive PlanStock & stock options4,000,000 
6,500,000 
Schedule of common stock for future issuance
As of June 30, 2022, the Company had reserved shares of Common Stock for future issuance for the following:
Common StockReserved Shares
Conversions of Preferred Stock and cumulative Preferred Stock dividends106,141 
Issuance upon exercise of stock options granted to current CEO1,000,000 
Issuance of shares to former CEO George Jensen upon the occurrence of a Cantaloupe transaction (1)
140,000 
Issuance under 2014 Stock Option Incentive Plan115,687 
Issuance under 2015 Equity Incentive Plan392,159 
Issuance under 2018 Equity Incentive Plan179,843 
Total shares reserved for future issuance1,933,830 
__________________________________________
(1)Represents 140,000 shares issuable to our former CEO George Jensen upon the occurrence of a "USA Transaction" as such term is defined in the Jensen Stock Agreement dated September 27, 2011 by and between the Company and George R. Jensen.
Schedule of stock option granted weighted average assumptions
The fair value of options granted during the years ended June 30, 2022, 2021, and 2020 was determined using the following assumptions:
For the year ended June 30,
202220212020
Expected volatility
73.2 - 74.6%
74.3 - 77.3%
74.6 - 90.1%
Expected life (years)
4.5 - 4.6
4.5
3.5 - 4.8
Expected dividends0.0%0.0%0.0%
Risk-free interest rate
1.0 - 2.9%
0.2-0.7%
0.3-1.6%
Schedule of information related to outstanding options
The following tables provide information about outstanding options for the years ended June 30, 2022, 2021, and 2020:
For the year ended June 30, 2022
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of period2,952,092 $6.97 5.6$14,419 
Granted904,500 $8.86 
Exercised(121,248)$6.30 $(53)
Forfeited(205,511)$8.09 
Expired— $— 
Outstanding options, end of period3,529,833 $7.41 4.5$194 
Exercisable options, end of period1,538,302 $6.79 4.5$183 
For the year ended June 30, 2021
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of period2,437,425 $6.43 6.2$1,411 
Granted755,000 $8.40 
Exercised(74,667)$3.81 $(601)
Forfeited(165,666)$6.90 
Expired— $— 
Outstanding options, end of period2,952,092 $6.97 5.6$14,419 
Exercisable options, end of period1,040,131 $6.52 5.1$5,558 

For the year ended June 30, 2020
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of period1,127,098 $4.84 4.3$2,917 
Granted2,075,760 $6.47 
Exercised(440,435)$2.48 $(595)
Forfeited(324,998)$6.55 
Expired— $— 
Outstanding options, end of period2,437,425 $6.43 6.2$1,411 
Exercisable options, end of period560,871 $6.01 4.8$559 
Schedule of nonvested share activity
A summary of the status of the Company’s nonvested common shares and RSUs as of June 30, 2022, 2021, and 2020, and changes during the years then ended is presented below:
SharesWeighted-Average
Grant-Date
Fair Value
Nonvested at June 30, 201938,971 $9.19 
Granted651,715 7.28 
Vested(109,050)7.52 
Forfeited(368,622)7.89 
Nonvested at June 30, 2020213,014 $6.50 
Granted187,848 10.33 
Vested(248,016)7.71 
Forfeited(15,000)$6.28 
Nonvested at June 30, 2021137,846 $9.57 
Granted507,729 7.33 
Vested(101,515)10.34 
Forfeited(95,152)8.89 
Nonvested at June 30, 2022448,908 $7.00 
Schedule of stock-based compensation expense A summary of the Company's stock-based compensation expense recognized during the years ended June 30, 2022, 2021, and 2020 is as follows (in thousands):
For the year ended June 30,
Award type202220212020
Stock options$4,424 $7,806 $2,181 
Stock grants1,824 1,269 848 
Total stock-based compensation expense$6,248 $9,075 $3,029 
A summary of the Company's unrecognized stock-based compensation expense as of June 30, 2022 is as follows:
As of June 30, 2022
Award typeUnrecognized Expense
(in thousands)		Weighted Average Recognition Period
(in years)
Stock options$4,223 2.4
Stock grants$2,131 1.5